EUVIMEDEUVIMED entdecken
Crossref

Combined treatment of intestinal dysbiosis in patients with chronic hepatitis c on the background of obesity

Mariya A Derbak, Vira V Vorobets, Yevheniia E Dankanych, Andrii D Sitkar, Olesya M Horlenko, Anatolija A Krasnova, Myroslava M Bletskan

Wiadomości Lekarskie · 29.05.2026 · (5) · 936-944

DOI: 10.36740/wlek/220828 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Wiadomości Lekarskie, online erschienen am 29.05.2026. Verfasst von Mariya A Derbak und 6 weiteren Autor:innen. Beteiligte Einrichtung: UZHHOROD NATIONAL UNIVERSITY, UZHHOROD, UKRAINE. Hauptthemen laut MEDLINE: Dysbiosis, Hepatitis C, Chronic, Obesity, Probiotics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Aim: To study the effectiveness of ursodeoxycholic acid use in the combined treatment of intestinal dysbiosis in patients with chronic Hepatitis C associated with obesity. Material and Methods 84 patients with CHC were examined. All patients underwent a microbiological study of stool, the levels of cytokine profile indicators were determined and the psychological status and the quality of life were assessed. Two groups were formed: 1 gr (n=40) – received LA-5 and BB-12 1 gtt. x TID and 2 gr (n=44) - LA-5 + BB-12 + UDCA 500 mg qhs for 1 month.

Results

As a result of simultaneous administration of LA-5 + BB-12 + UDCA in the above-mentioned doses, in 93.2% of patients with CHC an normalization of the act of defecation and the disappearance of symptoms of intestinal dysbiosis were found. In patients taking only LA-5 and BB-12, the above-mentioned positive changes were observed in 62.5%.

Conclusions

It was found that the additional prescription of UDCA in combination with a probiotic not only contributes to the restoration of colon microbiocenosis, but also improves the course of CHС, and increases the quality of life of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysbiosisHepatitis C, ChronicObesityProbioticsUrsodeoxycholic AcidCholagogues and CholereticsHumansMaleFemaleMiddle AgedAdultQuality of LifeTreatment OutcomeDrug Therapy, Combination

Stichwörter der Autor:innen

probioticsUrsodeoxycholic acidchronic Hepatitis Cdysbiosisobesity

Substanzen

Ursodeoxycholic AcidCholagogues and Choleretics

Autor:innen und Institutionen

  • UZHHOROD NATIONAL UNIVERSITY, UZHHOROD, UKRAINE.

Zitieren

APA

Derbak, M. A., Vorobets, V. V., Dankanych, Y. E., Sitkar, A. D., Horlenko, O. M., Krasnova, A. A., & Bletskan, M. M. (2026). Combined treatment of intestinal dysbiosis in patients with chronic hepatitis c on the background of obesity. Wiadomości Lekarskie, 936-944. https://doi.org/10.36740/wlek/220828

Vancouver

Derbak MA, Vorobets VV, Dankanych YE, Sitkar AD, Horlenko OM, Krasnova AA, et al. Combined treatment of intestinal dysbiosis in patients with chronic hepatitis c on the background of obesity. Wiadomości Lekarskie. 2026:936-944. doi:10.36740/wlek/220828

BibTeX
@article{Derbak2026,
  author = {Derbak, Mariya A and Vorobets, Vira V and Dankanych, Yevheniia E and Sitkar, Andrii D and Horlenko, Olesya M and Krasnova, Anatolija A and Bletskan, Myroslava M},
  title = {Combined treatment of intestinal dysbiosis in patients with chronic hepatitis c on the background of obesity},
  journal = {Wiadomości Lekarskie},
  year = {2026},
  number = {5},
  pages = {936--944},
  doi = {10.36740/wlek/220828}
}
Kostenlos starten →